Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitomycin and Ifosfamide (MI) as Salvage Therapy for Metastatic Pancreatic Adenocarcinoma: a Phase II Study.

NCT00967291 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT00967291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitomycin and Ifosfamide (MI) as Salvage Therapy for Metastatic Pancreatic Adenocarcinoma: a Phase II Study.
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2006
Completion date
June 30, 2008
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer